Insulin Market
According to Intent Market Research, the Insulin Market is expected to grow from USD 18.0 Billion in 2024-e at a CAGR of 3.4% to touch USD 21.9 Billion by 2030. The Insulin Market is dominated by key players such as, Novo Nordisk A/S, Sanofi S.A., Biocon Ltd., Eli Lilly and Company, Boehringer Ingelheim GmbH, and Wockhardt Ltd.